BioCentury
ARTICLE | Clinical News

Oral calcitonin: Began Phase II testing

January 16, 2001 8:00 AM UTC

Emisphere Technologies Inc. (EMIS), Tarrytown, N.Y. Product: Oral calcitonin Business: Musculoskeletal Therapeutic category: Drug delivery, Hormone replacement Target: Osteoclasts and osteoblasts Des...